Journal of Cancer Research and Clinical Oncology

, Volume 144, Issue 11, pp 2107–2107 | Cite as

RETRACTED ​ARTICLE: Transcriptional retargeting of herpes simplex virus for cell-specific replication to control cancer

  • Weihua Lou
  • Fang Ji
  • Jianing Fu
  • Zhiqiang Han
  • Wen DiEmail author
  • Ning ZhangEmail author
Review – Cancer Research

The Editor-in-Chief is retracting this article [1] because of overlap with other published articles, most significantly with [2–4]. Jianing Fu and Ning Zhang agree with this retraction. Weihua Lou, Fang Ji, Zhiqiang Han and Wen Di have not responded to correspondence about this retraction.

1. Lou W, Ji F, Fu J, Han Z, Di W, Zhang N. Transcriptional retargeting of herpes simplex virus for cell-specific replication to control cancer. J Cancer Res Clin Oncol (2018).

2. Mullen JT, Kasuya H, Yoon SS, Carroll NM, Pawlik TM, Chandrasekhar S, Nakamura H, Donahue JM, Tanabe KK. Regulation of herpes simplex virus 1 replication using tumor-associated promoters. Ann Surg. 2002;236:502–512

3. Kasuya H, Pawlik TM, Mullen JT, Donahue JM, Nakamura H, Chandrasekhar S, et al. Selectivity of an oncolytic herpes simplex virus for cells expressing the DF3/MUC1 antigen. Cancer Res. 2004;64:2561–7

4. Yamamura H, Hashio M, Noguchi M, Sugenoya Y, Osakada M, Hirano N, Sasaki Y, Yoden T, Awata N, Araki N, Tatsuta M, Miyatake SI, Takahashi K. Identification of the transcriptional regulatory sequences of human calponin promoter and their use in targeting a conditionally replicating herpes vector to malignant human soft tissue and bone tumors. Cancer Res. 2001;61:3969–77

Supplementary material

432_2017_2566_MOESM1_ESM.pdf (723 kb)
Former ​article ​version ​(PDF 723)

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Obstetrics and Gynecology, Ren Ji Hospital, School of MedicineShanghai Jiao Tong UniversityShanghaiChina
  2. 2.Shanghai Key Laboratory of Gynecologic OncologyShanghaiChina
  3. 3.Columbia Center for Translational ImmunologyColumbia University Medical CenterNew YorkUSA
  4. 4.Viri Biotechnology Company LimitedZhengzhouChina

Personalised recommendations